Log in to save to my catalogue

Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy

Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7484823

Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy

About this item

Full title

Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2020-07, Vol.111 (7), p.2248-2258

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Myeloid‐derived suppressor cells (MDSCs) play a crucial role in immunosuppression in tumor‐bearing hosts. MDSCs express arginase‐I and indoleamine 2,3‐dioxygenase; they suppress T‐cell function by reducing the levels of l‐arginine and l‐tryptophan, respectively. We examined the anticancer effects of supplementation of these amino acids in CT26 colo...

Alternative Titles

Full title

Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7484823

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7484823

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.14490

How to access this item